Dr. Janet Loesberg has been a strong leader in the pharmaceutical industry for over 25 years. She is currently at Johnson & Johnson as the Head of the Project Management Office at Janssen Research & Development. Prior to that she was the Vice President, Head of Medical Intercon Region at Bristol-Myers Squibb where she led the medical teams in Latin America, Brazil, China, Central Europe, Middle East and India.
At BMS, Dr. Loesberg was responsible for launching new Oncology innovative medicines bringing lifesaving treatments to patients. She led a team of over 300 medical professionals providing access to BMS medicines in 33 countries, which represents >85% of the world’s population. Recently, her focus was introducing these medicines in China providing hope for millions of patients diagnosed with lung cancer.
Throughout her career, Dr. Loesberg has worked tirelessly to advance gender parity in the workplace. She started an organization at BMS called Women In Science (WIS) which created programs to develop, mentor and sponsor women. WIS eventually grew to 3000+ members across many countries and was credited for retaining and advancing women to greater levels of authority. Later, at BMS, Dr. Loesberg helped to create the first People & Business Resource Group, called B-NOW (Bristol-Myers Squibb Network of Women). B-NOW, which is now its in 3rd year, has multiple chapters across the globe and changed the paradigm for women at BMS. This is due to Dr. Loesberg’s efforts.
Dr. Loesberg has been recognized by the Healthcare Business Women’s Association in 1997 with the Rising Star award, and in 2014 with the Luminary Award.
For the last 15 years, Dr. Loesberg has been an Alumni Ambassador – Recruiter for the University of Michigan for local NJ high schools. She has also served on the Board of Directors of Tamarack Camps in Michigan, which provides a camping experience for children and families independent of financial ability, and on the Board of Directors of Temple Har Shalom in Warren, New Jersey. Dr. Loesberg served as a trustee for the BMS Patient Assistance Foundation for over 10 years, which provides access to BMS medicines for patients in the US with financial hardship.
